These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16951028)

  • 21. The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?
    Feliciano J; Teper E; Ferrandino M; Macchia RJ; Blank W; Grunberger I; Colon I
    J Urol; 2008 Mar; 179(3):952-5; discussion 955. PubMed ID: 18207185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Apr; 56(14):332-6. PubMed ID: 17431378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Will fluoroquinolones ever be recommended for common infections in children?
    Schaad UB
    Pediatr Infect Dis J; 2007 Oct; 26(10):865-7. PubMed ID: 17901790
    [No Abstract]   [Full Text] [Related]  

  • 24. Fluoroquinolones versus beta-lactam based regimens for the treatment of osteomyelitis: a meta-analysis of randomized controlled trials.
    Karamanis EM; Matthaiou DK; Moraitis LI; Falagas ME
    Spine (Phila Pa 1976); 2008 May; 33(10):E297-304. PubMed ID: 18449029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoroquinolone-resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story.
    Nelson JM; Chiller TM; Powers JH; Angulo FJ
    Clin Infect Dis; 2007 Apr; 44(7):977-80. PubMed ID: 17342653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic quinolone antibiotics in children: a review of the use and safety.
    Grady RW
    Expert Opin Drug Saf; 2005 Jul; 4(4):623-30. PubMed ID: 16011441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic use of fluoroquinolone in children.
    Choi SH; Kim EY; Kim YJ
    Korean J Pediatr; 2013 May; 56(5):196-201. PubMed ID: 23741232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders.
    Noel GJ; Bradley JS; Kauffman RE; Duffy CM; Gerbino PG; Arguedas A; Bagchi P; Balis DA; Blumer JL
    Pediatr Infect Dis J; 2007 Oct; 26(10):879-91. PubMed ID: 17901792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Urinary tract infection and antibiotics: oral or intravenous route?].
    Bacchetta J; Cochat P
    Arch Pediatr; 2008 Aug; 15(8):1375-7. PubMed ID: 18639445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical studies of garenoxacin.
    Takagi H; Tanaka K; Tsuda H; Kobayashi H
    Int J Antimicrob Agents; 2008 Dec; 32(6):468-74. PubMed ID: 18790608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J; Profant M; Kostrica R; Waskin H
    Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
    Matthews SJ; Lancaster JW
    Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution.
    Cattaneo C; Quaresmini G; Casari S; Capucci MA; Micheletti M; Borlenghi E; Signorini L; Re A; Carosi G; Rossi G
    J Antimicrob Chemother; 2008 Mar; 61(3):721-8. PubMed ID: 18218645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nadifloxacin: a quinolone for topical treatment of skin infections and potential for systemic use of its active isomer, WCK 771.
    Jacobs MR; Appelbaum PC
    Expert Opin Pharmacother; 2006 Oct; 7(14):1957-66. PubMed ID: 17020421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Quinolones--a cure which became a threat. Accelerating resistance development demands stricter indications].
    Lytsy B; Cars O; Torell E
    Lakartidningen; 2005 Nov 28-Dec 4; 102(48):3651-6, 3659. PubMed ID: 16416945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluoroquinolone prescriptions in a teaching hospital: a prospective audit.
    Pulcini C; Mondain V; Lieutier F; Mousnier A; Roger PM; Dellamonica P
    Scand J Infect Dis; 2007; 39(11-12):1013-7. PubMed ID: 17852936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prescribing practices of fluoroquinolones in Tunisia].
    Hachfi W; Kaabia N; Bougmiza I; Bellazreg F; Hattab Z; Ben Lasfar N; Bahri F; Letaief A
    Rev Med Liege; 2011 Apr; 66(4):205-8. PubMed ID: 21638839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
    Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F
    Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergency department management of acute migraine in children in Canada: a practice variation study.
    Richer L; Graham L; Klassen T; Rowe B
    Headache; 2007 May; 47(5):703-10. PubMed ID: 17501852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.